MolecuLight is attending the IPAWS & Tissue Repair Summit 2026 in New Orleans at booth #5 from September 10 to 11, 2026.

Public source

Publisher name

Public post

We’re attending IPAWS & Tissue Repair Summit 2026! Join the MolecuLight team in New Orleans at booth #5, September 10–11, for two days of practical learning, meaningful…

Log in to read the full post

Company

MolecuLight

i:X & DX point-of-care detection of wounds containing elevated bacterial burden & digital wound measurement #moleculight

Industry
Medical Equipment Manufacturing
Location
Toronto, CA
Company size
51–200 employees

About MolecuLight

MolecuLight Inc. a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s suite of commercially released devices, including the MolecuLight i:X® and DX™ fluorescence imaging systems and their accessories, provide point-of-care handheld imaging devices for the global wound care market for the real-time detection of wounds containing elevated bacterial burden > 10^4 CFU/g (when used with clinical signs and symptoms) and for digital wound measurement #moleculight

See more

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.